Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma
Open Access
- 31 October 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (15), 2639-2646
- https://doi.org/10.1016/j.ejca.2006.05.035
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomasOncogene, 2004
- Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisBlood, 2004
- Characterization of the long pentraxin PTX3 as a TNFα-induced secreted protein of adipose cellsJournal of Lipid Research, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic miceOncogene, 2000
- Pathology and GeneticsMultiple Sclerosis Journal, 1998
- Characterization of the Promoter for the Human Long Pentraxin PTX3Journal of Biological Chemistry, 1997
- EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.Journal of Clinical Investigation, 1997
- Molecular events in adipocyte developmentPharmacology & Therapeutics, 1994
- A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.Genes & Development, 1994